Agios Pharmaceuticals, Inc. (AGIO) vs Mesoblast Limited (MESO)
- Agios Pharmaceuticals, Inc. AGIO 31.32 −3.09%
- Mesoblast Limited MESO 13.28 −4.80%
Agios Pharmaceuticals, Inc. and Mesoblast Limited are both Biotechnology companies. Agios Pharmaceuticals, Inc. and Mesoblast Limited are of similar size ($1.9B and $1.8B). Agios Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 140.6% against −26.5%. Agios Pharmaceuticals, Inc. has the higher net margin (−418.2% vs −1,091.7%) and the lower return on invested capital (−70.2% vs 0.00%). Across the 18 metrics below, Mesoblast Limited leads on 10 and Agios Pharmaceuticals, Inc. on 8.
Valuation
Profitability
| Metric | AGIO | MESO | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.99% | (269.72%) | 65.16% |
| Operating margin | (466.78%) | (826.28%) | 0.00% |
| Net margin | (418.24%) | (1,091.71%) | 0.00% |
| Free cash flow margin | (371.43%) | 0.00% | 0.00% |
| Return on equity | (34.34%) | 0.00% | (56.36%) |
| Return on assets | (31.89%) | 0.00% | (48.04%) |
| Return on invested capital | (70.24%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack